Menu Fermer

Articles sur Biologics

Ensemble des articles

Broadly neutralizing antibodies are able to recognize multiple strains of HIV at once. Naeblys/iStock via Getty Images Plus

HIV therapies currently need to be taken regularly for life – longer-lasting antibody treatments could one day offer an equally effective one-shot alternative

Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
Your genetic material instructs your cells to produce the proteins encoded in it. Juan Gaertner/Science Photo Library via Getty Images

Helping cells become better protein factories could improve gene therapies and other treatments – a new technique shows how

Gene therapies and vaccines are often injected into muscle cells that are inefficient at producing desired proteins. Making them work more like liver cells could lead to better treatment outcomes.
While pills come in many shapes and sizes, they all eventually reach your bloodstream and travel throughout your body. Vadim Sazhniev/iStock via Getty Images

How do drugs know where to go in the body? A pharmaceutical scientist explains why some medications are swallowed while others are injected

From tablets and patches to ointments and infusions, the best way to deliver a drug is the one that gets the right amount to the right place.
Monaco and Japan have some of the highest life expectancies in the world. But calculating an individual’s life expectancy will require taking data analysis several steps further. SHUTTERSTOCK

Don’t die wondering: apps may soon be able to predict your life expectancy, but do you want to know?

Predicting life expectancy remains in the realm of science fiction, but it may soon be possible. Are we prepared for such information? And who else would benefit from this knowledge?
Protecting the patents of expensive medicines for longer would affect low-income countries. Jason Reed/ReutersPics

Time for costly medicine monopolies to go from TPP trade talks

Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend.
The cells inside this bioreactor are the real pharmaceutical factories. Sanofi Pasteur

Biologics: The pricey drugs transforming medicine

Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here’s where they come from and how they work.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Insulin, which is used for controlling diabetes and has been in the market for 30 years, was the first biologic. Yusmar Yahaya/Flickr

Explainer: what are biologics and biosimilars?

Biologics are widely accepted as the most effective way of treating certain diseases. They have become the fastest-growing class of therapeutic compounds, with about 300 now available for human use.
A group of oncologists have called on cancer patients to challenge the high prices charged by pharmaceutical companies for new cancer drugs. ep_jhu/Flickr

If we don’t talk about value, cancer drugs will become terminal for health systems

Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.

Les contributeurs les plus fréquents

Plus